Ken
Henderson - Med Five Results
Evaluation
by Dr. James Roberts - Information obtained by
phone interview 10/01 with Mr. Henderson and Dr.
Roberts’ review of Ken’s lab data.
Ken gave us permission to share his story with
you. We cannot say with certainty that the changes
described below did not occur by chance. Just
because Ken’s lipid panel seems to have
improved with the addition of Rejuvetate to pre-existing
pharmacologic lipid lowering therapy, it doesn’t
mean that others will experience the same effect.
Crestor plus Med Five and Ken Henderson’s
Lipid Panel
Synergize
with Med Five
Ken
doesn’t smoke, his blood pressure is normal,
and so is his blood sugar. Ken minimizes red meat
and takes in his share of fruits and vegetables
- but his cholesterol is high - or at least it
was. One year ago, Ken’s doctor put him
on Crestor, a statin lipid lowering agent, at
a starting dose of 10 mg each day (the maximum
dose is 40 mg/day – you start low and advance
the dose as required). On Crestor, Ken’s
cholesterol fell from 258 to 172 mg/dl, with an
LDL (bad cholesterol) of 105 mg/dl.
In
persons free of known cardiovascular disease,
our goal in lipid lowering therapy has been an
LDL value of 100, and Ken was nearly there. Several
recent studies, however, suggest that an LDL of
70 mg/dl might be the optimal target* An increased
dose of Crestor would most certainly have lowered
Ken’s LDL to 70, but when we increase the
dose of statin lipid lowering therapy, we also
increase your risk for a treatment related side-effect,
especially muscle inflammation and liver chemistry
problems.
In
early 2/05, Ken added Rejuvetate to his program,
while continuing on Crestor at 10 mg. Ken continues
to feel well, but from the perspective of Ken’s
lipid panel, it’s been a down hill course.
One month into the Crestor-Rejuvetate combination,
there was no change in Ken’s LDL and Cholesterol
levels, actually they bumped up a bit, but Ken’s
Triglycerides decreased from 191 to 110. In mid-June,
now 4 & ½ months on Crestor + Rejuvetate,
Ken’s Cholesterol had dropped markedly,
to 139 mg/dl, and his Triglyceride level was down
to 83 (Ken did not tighten his diet further or
begin an exercise program between 1/31 and 6/14).
Statin
drug therapy works rapidly, within a matter of
weeks. Statins inhibit the enzymes that synthesize
cholesterol in the liver, and you see the peak
effect in four weeks. De-poisoning and stimulating
the enzymes of reverse cholesterol transport takes
longer, but from the perspective of your long-term
health, patience is a virtue. It is not surprising
that it took some time for Crestor + Rejuvetate
to show a benefit over Crestor drug therapy alone.
Also, Ken’s HDL fell, on face value not
a desirable result, but we know that whenever
the total and LDL Cholesterol values drop considerably,
the HDL (good Cholesterol) value will inevitably
decrease in tandem. Therefore we focus on the
HDL%, the percentage of total Cholesterol made
up of the good HDL, and here Crestor + Rejuvetate
worked out well.
Kenneth
Henderson – Analysis
We
aren’t anti-medicine or anti-drug therapy.
We aren’t anti-anything, but at Med Five
we are pro dealing with all the causes of plaque
buildup. I’m an invasive cardiologist and
one half of my patients are on statin cholesterol
lowering medications. Statins block the formation
of cholesterol and have an anti-inflammatory effect,
a double positive for my patients with high cholesterol
and inflamed arteries. However, there are many
other causes of high cholesterol, and many causes
of vascular and degenerative disease in general,
that the statins don’t address – so
we will - issues such as:
1.
Reverse Cholesterol Transport – Phosphatidylcholine
(PC) stimulates the enzymes of reverse cholesterol
transport, so we put PC in Rejuvetate.
2.
Metal Detoxification – Lead, Cadmium, and
especially Mercury will poison the enzymes of
reverse cholesterol transport (along with many
other critical body functions). EDTA, Vitamin
C, and DMSA help the body rid itself of these
toxic metals, so we included them in Rejuvetate.
We are not making health claims, but published,
peer-reviewed studies (some written before I was
born) ** tell us that oral EDTA will lower Cholesterol
levels in humans – so we put EDTA in Rejuvetate
– pretty simple.
3.
Gum Disease – Yes, gum disease elevates
your Cholesterol, and it leads to vascular inflammation
and CRP elevation, so we go after this problem
with Lysozyme in our mouth rinse.
4.
Infection/Inflammation – Infection increases
cholesterol – your body makes more of the
stuff to neutralize bacterial toxins. Our response
is to include Mushroom Polysaccharide Extracts
in Rejuvetate, aiming to improve the function
of your immune system.
OK,
back to Ken’s situation – you have
Crestor providing an anti-inflammatory effect
and blocking cholesterol formation and Rejuvetate
depoisoning and stimulating the enzymes of reverse
cholesterol transport, while stimulating immune
function to combat infection and inflammation
in the mouth and elsewhere, and what do you get?
You get a synergism and in Ken’s case a
drop in cholesterol to 130 mg/dl, with a Triglycerides
of 83 and an HDL% of 33. This seems like a good
idea to us, so we invite you to:
Synergize
with Med Five
*
This is still being worked out, but societies
where heart disease is unheard of have LDL values
in this range. A similar situation definitely
exists for blood sugar. While the “normal
limit” for fasting blood sugar is up to
110 mg/dl, and our medical treatment goal is a
sugar around 100, we know with certainty that
individuals with sugars in the 70-80 range are
at much lower cardiovascular risk than are individuals
with sugars in the 90-110 range.
**
Perry, HM., Depression of Cholesterol Levels in
Human Plasma following Ethylenediamine Tetracetate
and Hydralazine. Journal of Chronic Diseases 2:520-533,
1955
Schroeder,
Henry A., A Practical Method for the Reduction
of Plasma Cholesterol in Humans. Journal of Chronic
Diseases 4:46468, Nov., 1956.
James
C. Roberts MD FACC 10/07/05
|